A report on this study by Srivastava et al. (130) using ROR1 CAR-T cells manufactured carrying R12 scFv, 4-1BB and CD3ζ signaling domains showed that in three patients (ROR1+ TNBC or ROR1+ NSCLC), the ROR1 CAR-T cells expanded as evidenced in peripheral blood. Here, ROR1 is linked to non-small cell lung carcinoma.